Chronic Inflammatory Demyelinating Polyneuropathy: Considerations for Diagnosis, Management, and Population HealthByMelody Ryan, PharmD, MPH,Stephen J. Ryan, MD, MASeptember 25th 2018
The Economic Burden and Managed Care Implications of Chronic Inflammatory Demyelinating PolyneuropathyByGary M. Owens, MDSeptember 25th 2018
